Figure 2
From: CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer
Genomic distribution of CDKN2A mutations. (a) UCMC cohort. (b) MSKCC cohort. Shown are amino acid changes due to mutations. Of note, loss-of-function due to gene loss are not presented in plot.
